These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3935310)

  • 1. Influence of supplemental ascorbate on the antitumor activity of 5-hydroxydopa, a purported cytotoxic metabolite.
    Pierson HF; Meadows GG
    Cancer Lett; 1985 Nov; 29(2):157-68. PubMed ID: 3935310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of peroxidation in murine melanoma by dietary tyrosine-phenylalanine restriction, levodopa methylester chemotherapy, and sodium ascorbate supplementation.
    Pierson HF; Meadows GG
    J Natl Cancer Inst; 1985 Sep; 75(3):507-16. PubMed ID: 3861901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
    Pierson HF; Meadows GG
    Cancer Res; 1983 May; 43(5):2047-51. PubMed ID: 6831435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by taurine of the toxicity of taumustine, a compound with antitumor activity.
    Pierson HF; Fisher JM; Rabinovitz M
    J Natl Cancer Inst; 1985 Nov; 75(5):905-9. PubMed ID: 3863989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH; Wallace TL; Richard KA; Tracey DE
    Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism.
    Matsuba Y; Edatsugi H; Mita I; Matsunaga A; Nakanishi O
    Cancer Chemother Pharmacol; 2000; 46(1):1-9. PubMed ID: 10912571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells.
    Morrison ME; Yagi MJ; Cohen G
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2960-4. PubMed ID: 3921968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.
    Lippman MM; Laster WR; Abbott BJ; Venditti J; Baratta M
    Cancer Res; 1975 Apr; 35(4):939-45. PubMed ID: 1116151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo activity on murine tumors of a novel antitumor compound, N-beta-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo[a]phenazine-6-carboxamide sodium salt (NC-190).
    Nakaike S; Yamagishi T; Samata K; Nishida K; Inazuki K; Ichihara T; Migita Y; Otomo S; Aihara H; Tsukagoshi S
    Cancer Chemother Pharmacol; 1989; 23(3):135-9. PubMed ID: 2924370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of concomitant infusion of thymidine and inosine on methotrexate activity in normal and P388-bearing mice.
    Uitendaal MP; Schornagel JH; Leyva A; Pinedo HM
    Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1527-32. PubMed ID: 6542016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo anti-tumor activity of L-glutamic acid gamma-monohydroxamate against L1210 leukemia and B16 melanoma.
    Vila J; Thomasset N; Navarro C; Doré JF
    Int J Cancer; 1990 Apr; 45(4):737-43. PubMed ID: 2323850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental antitumor activity of BMY-28090, a new antitumor antibiotic.
    Schurig JE; Bradner WT; Basler GA; Rose WC
    Invest New Drugs; 1989 Jul; 7(2-3):173-8. PubMed ID: 2793369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbate in the treatment of experimental transplanted melanoma.
    Meadows GG; Pierson HF; Abdallah RM
    Am J Clin Nutr; 1991 Dec; 54(6 Suppl):1284S-1291S. PubMed ID: 1962584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
    McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
    Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA; Wodinsky I
    Cancer; 1983 Feb; 51(4):600-5. PubMed ID: 6401590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective toxicity of 6-hydroxydopa for melanoma cells.
    Wick MM; Byers L; Ratliff J
    J Invest Dermatol; 1979 Feb; 72(2):67-9. PubMed ID: 422870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors.
    Canti G; Lattuada D; Morelli S; Nicolin A; Cubeddu R; Taroni P; Valentini G
    Cancer Lett; 1995 Jul; 93(2):255-9. PubMed ID: 7621437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.